[
    [
        {
            "time": "2020-12-31",
            "original_text": "华熙生物(688363)2020年年报点评：整体符合预期 品牌知名度提升带动功能性护品高增",
            "features": {
                "keywords": [
                    "华熙生物",
                    "年报",
                    "品牌知名度",
                    "功能性护肤品",
                    "高增长"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "化妆品",
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "华熙生物(688363)2020年年报点评：整体符合预期 品牌知名度提升带动功能性护品高增",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 5,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        },
        {
            "time": "2021-03-15",
            "original_text": "华熙生物(688363)：功能性护肤品翻倍增长 玻尿酸龙头多品类多业务期待发力",
            "features": {
                "keywords": [
                    "华熙生物",
                    "功能性护肤品",
                    "玻尿酸",
                    "多品类",
                    "多业务"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "化妆品",
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "华熙生物(688363)：功能性护肤品翻倍增长 玻尿酸龙头多品类多业务期待发力",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 5,
                "Time_Proximity": 5,
                "Headline_Structure": 8,
                "Source_Recency": 6
            }
        },
        {
            "time": "2021-04-01",
            "original_text": "这个品类增长超1倍！华熙生物2020年化妆品业务暴走，玻尿酸食品仍难“出圈”",
            "features": {
                "keywords": [
                    "华熙生物",
                    "化妆品业务",
                    "玻尿酸食品",
                    "增长超1倍"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "化妆品",
                    "食品"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "这个品类增长超1倍！华熙生物2020年化妆品业务暴走，玻尿酸食品仍难“出圈”",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 5,
                "Headline_Structure": 9,
                "Source_Recency": 6
            }
        },
        {
            "time": "2021-04-10",
            "original_text": "玻尿酸第一股华熙生物：2020年超5成收入来自化妆品，销售费用增111%占营收4成",
            "features": {
                "keywords": [
                    "华熙生物",
                    "玻尿酸",
                    "化妆品",
                    "销售费用",
                    "营收占比"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "化妆品"
                ],
                "causal_factor": "true",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "玻尿酸第一股华熙生物：2020年超5成收入来自化妆品，销售费用增111%占营收4成",
                "Correlation": 10,
                "Sentiment": 6,
                "Importance": 9,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 5,
                "Headline_Structure": 8,
                "Source_Recency": 6
            }
        },
        {
            "time": "2021-05-01",
            "original_text": "平安证券给予华熙生物推荐评级，终端业务发展良好，推动营收规模快速上升",
            "features": {
                "keywords": [
                    "华熙生物",
                    "平安证券",
                    "推荐评级",
                    "终端业务",
                    "营收规模"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "化妆品"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "平安证券给予华熙生物推荐评级，终端业务发展良好，推动营收规模快速上升",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 8,
                "Market_Scope": 3,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "2021-06-10",
            "original_text": "火出圈的华熙生物披露年报：2020年营收26.33亿元 一半靠卖护肤品",
            "features": {
                "keywords": [
                    "华熙生物",
                    "年报",
                    "营收",
                    "护肤品"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "化妆品"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "火出圈的华熙生物披露年报：2020年营收26.33亿元 一半靠卖护肤品",
                "Correlation": 10,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 5,
                "Headline_Structure": 9,
                "Source_Recency": 6
            }
        },
        {
            "time": "2021-07-15",
            "original_text": "社保基金新进4股，增持2股可关注（附股）",
            "features": {
                "keywords": [
                    "社保基金",
                    "新进",
                    "增持",
                    "华熙生物"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "综合"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "社保基金新进4股，增持2股可关注（附股）",
                "Correlation": 5,
                "Sentiment": 6,
                "Importance": 6,
                "Impact": 5,
                "Duration": 4,
                "Entity_Density": 4,
                "Market_Scope": 6,
                "Time_Proximity": 5,
                "Headline_Structure": 7,
                "Source_Recency": 5
            }
        }
    ]
]